Tone mix
Week by week 51 weeks
Share of ARS Pharmaceuticals, Inc. Common Stock's 338 headlines over the last 52 weeks by the model's call, and the same mix week by week.
Biggest swings in the last year
The weeks whose tone moved furthest from the 8-week average, with the story most outlets carried that week.
- Week of Sep 15, 2025 · tone +98ARS Pharmaceuticals, Inc. (SPRY): A Bull Case Theory+98
- Week of Mar 23, 2026 · tone +99ARS Pharmaceuticals, Inc.: ARS Pharmaceuticals Receives FDA Approval to Remove Age Requirement From neffy 1 mg (epinephrine nasal spray) Label+71
- Week of Aug 18, 2025 · tone -100Q3 EPS Estimate for ARS Pharmaceuticals Decreased by Analyst-67
- Week of Apr 6, 2026 · tone +99Weekly Buzz: SPRY Gains FDA Nod; EU Expands Kerendia Label; Eli Lilly Acquires CNTA; BIIB Snaps Up APLS+56
- Week of Mar 24, 2025 · tone -20Leerink Partnrs Has Pessimistic View of SPRY FY2028 Earnings-54
- Week of Apr 20, 2026 · tone +97Northland Highlights ARS Pharmaceuticals, Inc. (SPRY) Needle-Free Therapy as Major Innovation Driver+48
Daily headline tone, last 90 sessions
Hover a session for its totals; click to pin.
Each point is the average score of the headlines about ARS Pharmaceuticals, Inc. Common Stock in one trading session, with the 8-session average drawn through it. Sessions with no headline about the company have no point.
Tone by period
Show the table · 3 rows, 3 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Last 7 sessions | 1 | 0 |
| Last 30 sessions | 35 | -13 |
| Last 90 sessions | 268 | -23 |
No matching rows. Clear the filter to see all records.
Every headline in the period counts equally.
Headlines on Friday, November 6, 2026
1 headline, average tone 0: 0 positive, 1 neutral and 0 negative. Showing all 1.
- www.themarketsdaily.com · 1 outletARS Pharmaceuticals Q3 Earnings Call HighlightsNeutral
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| ARS Pharmaceuticals Q3 Earnings Call Highlights | www.themarketsdaily.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Monday, October 26, 2026
1 headline, average tone 0: 0 positive, 1 neutral and 0 negative. Showing all 1.
- www.tickerreport.com · 1 outletFinancial Analysis: LENZ Therapeutics (NASDAQ:LENZ) & ARS Pharmaceuticals (NASDAQ:SPRY)Neutral
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Financial Analysis: LENZ Therapeutics (NASDAQ:LENZ) & ARS Pharmaceuticals (NASDAQ:SPRY) | www.tickerreport.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Wednesday, October 21, 2026
1 headline, average tone 0: 0 positive, 1 neutral and 0 negative. Showing all 1.
- www.dailypolitical.com · 1 outletContrasting ARS Pharmaceuticals (NASDAQ:SPRY) and Theravance Biopharma (NASDAQ:TBPH)Neutral
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Contrasting ARS Pharmaceuticals (NASDAQ:SPRY) and Theravance Biopharma (NASDAQ:TBPH) | www.dailypolitical.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Tuesday, October 6, 2026
4 headlines, average tone 0: 0 positive, 4 neutral and 0 negative. Showing all 4.
- www.dailypolitical.com · 1 outletHead-To-Head Contrast: ARS Pharmaceuticals (NASDAQ:SPRY) and Nutriband (NASDAQ:NTRB)Neutral
- www.pr-inside.com · 1 outletLevi & Korsinsky Notifies ARS Pharmaceuticals, Inc. (SPRY) Shareholders ...Neutral
- www.pr-inside.com · 1 outletLost Money on ARS Pharmaceuticals, Inc. (SPRY)? Urged to Join Class ...Neutral
- www.pr-inside.com · 1 outletLost Money on ARS Pharmaceuticals, Inc. (SPRY)? Join Class Action Before ...Neutral
Show the table · 4 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Head-To-Head Contrast: ARS Pharmaceuticals (NASDAQ:SPRY) and Nutriband (NASDAQ:NTRB) | www.dailypolitical.com | 1 | Neutral |
| Levi & Korsinsky Notifies ARS Pharmaceuticals, Inc. (SPRY) Shareholders ... | www.pr-inside.com | 1 | Neutral |
| Lost Money on ARS Pharmaceuticals, Inc. (SPRY)? Urged to Join Class ... | www.pr-inside.com | 1 | Neutral |
| Lost Money on ARS Pharmaceuticals, Inc. (SPRY)? Join Class Action Before ... | www.pr-inside.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Monday, October 5, 2026
7 headlines, average tone -36: 0 positive, 4 neutral and 3 negative. Showing all 7.
- www.prnewswire.com · 2 outletsARS Pharmaceuticals Deadline: SPRY Investors Have Opportunity to Lead ARS Pharmaceuticals, Inc. Securities Fraud LawsuitNeutral
- www.pr-inside.com · 2 outletsSecurities Lawsuit Alert: ARS Pharmaceuticals, Inc. (SPRY) - Contact ...Neutral
- www.pr-inside.com · 1 outletSecurities Fraud Class Action Filed Against ARS Pharmaceuticals, Inc. ...Negative
- www.pr-inside.com · 1 outletRecover Investment Losses: Class Action Initiated Against ARS Pharmaceuticals, ...Negative
- www.pr-inside.com · 1 outletClass Action Lawsuit Filed: ARS Pharmaceuticals, Inc. (SPRY) - Join ...Negative
- www.pr-inside.com · 1 outletLost Money on ARS Pharmaceuticals, Inc. (SPRY)? Urged to Join Class ...Neutral
- www.pr-inside.com · 1 outletInvestor Alert: Deadline Approaching to Join ARS Pharmaceuticals, Inc. ...Neutral
Show the table · 7 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| ARS Pharmaceuticals Deadline: SPRY Investors Have Opportunity to Lead ARS Pharmaceuticals, Inc. Securities Fraud Lawsuit | www.prnewswire.com | 2 | Neutral |
| Securities Lawsuit Alert: ARS Pharmaceuticals, Inc. (SPRY) - Contact ... | www.pr-inside.com | 2 | Neutral |
| Securities Fraud Class Action Filed Against ARS Pharmaceuticals, Inc. ... | www.pr-inside.com | 1 | Negative |
| Recover Investment Losses: Class Action Initiated Against ARS Pharmaceuticals, ... | www.pr-inside.com | 1 | Negative |
| Class Action Lawsuit Filed: ARS Pharmaceuticals, Inc. (SPRY) - Join ... | www.pr-inside.com | 1 | Negative |
| Lost Money on ARS Pharmaceuticals, Inc. (SPRY)? Urged to Join Class ... | www.pr-inside.com | 1 | Neutral |
| Investor Alert: Deadline Approaching to Join ARS Pharmaceuticals, Inc. ... | www.pr-inside.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
How the score works
A headline's tone is not a forecast of the share price. Read the headlines themselves before acting on an average.
Which headlines count
Headlines come from the GDELT global news feed from 2019-09-23 on. A headline counts only when a model judges it to be about ARS Pharmaceuticals, Inc. Common Stock, not a passing mention.
How each headline is scored
The model calls each headline positive, neutral or negative news for the company. A period's tone is the share of positive minus negative headlines, from -100 (all negative) to +100 (all positive).
When a headline counts
Headlines published by 9:15 a.m. New York time belong to that day's session. Later and weekend headlines move to the next trading session.
Repeated stories
When several outlets carry the same headline, it counts once per session.